Cargando…
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
Highly glycolytic cancer cells prevent intracellular acidification by excreting the glycolytic end-products lactate and H(+) via the monocarboxylate transporters 1 (MCT1) and 4 (MCT4). We report that syrosingopine, an anti-hypertensive drug, is a dual MCT1 and MCT4 inhibitor (with 60-fold higher pot...
Autores principales: | Benjamin, Don, Robay, Dimitri, Hindupur, Sravanth K., Pohlmann, Jens, Colombi, Marco, El-Shemerly, Mahmoud Y., Maira, Sauveur-Michel, Moroni, Christoph, Lane, Heidi A., Hall, Michael N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6302548/ https://www.ncbi.nlm.nih.gov/pubmed/30540938 http://dx.doi.org/10.1016/j.celrep.2018.11.043 |
Ejemplares similares
-
Syrosingopine sensitizes cancer cells to killing by metformin
por: Benjamin, Don, et al.
Publicado: (2016) -
Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020) -
Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023) -
MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017) -
Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)